MDCG Revised Guidance on MDR Application for Legacy Devices
The article highlights the key points related to the regulatory status of legacy devices.
The article highlights the key points related to the regulatory status of legacy devices.
The new article provides additional clarifications regarding specific aspects of the regulatory approach to be followed.
The article highlights the key points related to the regulatory status of in vitro diagnostic medical devices under the existing legal framework.
The final article of the cycle is dedicated to combination products and their specific regulatory nature.
The new article further elaborates on the key matters associated with substance-based products intended to be marketed and used within the EU.
The new article describes in detail the regulatory status of herbal products.
#WednesdayWebinar Join us for our upcoming webinar Global Regulatory Changes to Expect in 2025 January 22, 2025 at 10 AM ET
Register Now